Log In
BCIQ
Print this Print this
 

GSK610677

Also known as: 610677

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionInhaled formulation of a p38 inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today